Amgen CEO Shines Light On Opportunities For Accelerated Drug Pathways
Collaborations, Agility Also Key
Amgen CEO Robert Bradway spotlights opportunities to up the tempo of drug discovery and development, drawing from the success of COVID-19 vaccines, and touches on the company's breakthrough treatment Lumakras and efforts in gastric cancer.
